We are live on ! Find out more
CM

CM Management Portfolio holdings

AUM $120M
1-Year Est. Return 37.12%
This Fund
S&P 500
This Quarter Est. Return
+3.11%
1 Year Est. Return
+37.12%
3 Year Est. Return
+141.34%
5 Year Est. Return
+139.46%
10 Year Est. Return
AUM
$83.7M
AUM Growth
-$5.84M
Cap. Flow
-$4.89M
Cap. Flow %
-5.84%
Top 10 Hldgs %
41.07%
Holding
80
New
9
Increased
19
Reduced
18
Closed
8

Sector Composition

1 Healthcare 38.52%
2 Energy 10.31%
3 Industrials 9.01%
4 Financials 8.76%
5 Materials 8.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ELDN icon
51
Eledon Pharmaceuticals
ELDN
$301M
$535K 0.64%
234,800
-10,200
-4% -$25.2K
WBD icon
52
Warner Bros
WBD
$68.3B
$474K 0.57%
50,000
-25,000
-33% -$282K
SMSI icon
53
Smith Micro Software
SMSI
$14.6M
$389K 0.46%
4,625
-750
-14% -$65.5K
LTRN icon
54
Lantern Pharma
LTRN
$36.1M
$362K 0.43%
60,000
+10,000
+20% +$50.1K
BRKL
55
DELISTED
Brookline Bancorp
BRKL
$354K 0.42%
+25,000
New +$334K
GANX icon
56
Gain Therapeutics
GANX
$70M
$344K 0.41%
110,000
-15,000
-12% -$46.9K
OSPN icon
57
OneSpan
OSPN
$577M
$336K 0.4%
30,000
-60,000
-67% -$689K
NEUE
58
DELISTED
NeueHealth
NEUE
$325K 0.39%
6,250
-1,250
-17% -$90.9K
AMRX icon
59
Amneal Pharmaceuticals
AMRX
$5.85B
$299K 0.36%
150,000
NKTR icon
60
Nektar Therapeutics
NKTR
$2.28B
$283K 0.34%
8,333
+5,000
+150% +$242K
SPPI
61
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$249K 0.3%
675,000
-125,000
-16% -$52.7K
PAAS icon
62
Pan American Silver
PAAS
$17.5B
$245K 0.29%
15,000
SSRM icon
63
SSR Mining
SSRM
$5.28B
$235K 0.28%
+15,000
New +$220K
BCEL
64
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$220K 0.26%
275,000
+25,718
+10% +$32.7K
FEMY icon
65
Femasys
FEMY
$9.3M
$217K 0.26%
12,069
-2,931
-20% -$68.4K
VNO icon
66
Vornado Realty Trust
VNO
$7.71B
$208K 0.25%
10,000
-30,000
-75% -$687K
CRIS icon
67
Curis
CRIS
$9.32M
$138K 0.16%
+625
New +$183K
CGAU
68
Centerra Gold
CGAU
$2.97B
$130K 0.16%
+25,000
New +$124K
CTMX icon
69
CytomX Therapeutics
CTMX
$795M
$120K 0.14%
+75,000
New +$111K
NBSE
70
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
$67K 0.08%
17,500
-5,000
-22% -$25.6K
ADVM
71
DELISTED
Adverum Biotechnologies
ADVM
$58K 0.07%
+10,000
New +$75.8K
KRON
72
DELISTED
Kronos Bio
KRON
$49K 0.06%
+30,000
New +$69.1K
ET icon
73
Energy Transfer Partners
ET
$70B
-75,000
Closed -$827K
FDX icon
74
FedEx
FDX
$75.6B
-5,000
Closed -$742K
JPM icon
75
JPMorgan Chase
JPM
$912B
-10,000
Closed -$1.04M

Similar funds

CM Management's Q4 2022 Portfolio in Review

As of Q4 2022, CM Management held 80 positions worth $83.7M, down 6.5% from $89.6M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

CM Management withdrew a net $4.89M in Q4 2022, closing 8 positions and reducing 18 holdings. Its most notable exit was RealNetworks Inc, an estimated $1.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 39% of assets, up from 37% a quarter earlier, followed by Energy and Industrials.

Against the trend, CM Management opened a new position in Agnico Eagle Mines worth $780K.

  • CM Management's largest Q4 2022 buy was Agnico Eagle Mines: 15,000 shares worth $780K.
  • CM Management added most to Southwestern Energy Company in Q4 2022, an estimated $986K increase.
  • CM Management's biggest Q4 2022 reduction was Kyndryl, cutting an estimated $1.01M.
  • CM Management fully exited RealNetworks Inc in Q4 2022, selling an estimated $1.8M.
  • CM Management's ten largest holdings make up 41% of its $83.7M portfolio in Q4 2022.
  • CM Management opened 9 new positions and closed 8 in Q4 2022.
  • CM Management's portfolio value fell 6.5% quarter-over-quarter to $83.7M.

Based on CM Management's 13F filing for Q4 2022, filed 9 Feb 2023.